...
机译:新型心肌可降解支架结合生长因子,肝素和干细胞治疗急性心肌梗死
1Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China 2Department of Surgery, TEDA International Cardiovascular Hospital, No. 61, Third Avenue, TEDA, Tianjin 300457, China 3Department of Nuclear Medicine, TEDA International Cardiovascular Hospital, Tianjin, China 4Department of Ultrasound, TEDA International Cardiovascular Hospital, Tianjin, China 5Institute of Basic Medical Sciences, Center of Excellence in Tissue Engineering 6Institute of Biomedical Engineering, Peking Union Medical College, Beijing, China 7TEDA International Cardiovascular Hospital, Nankai University Medical College, Tianjin, China 8Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China 9Starr Academic Center, Providence Heart &
Vascular Institute, Oregon Health;
机译:新型心肌可降解支架结合生长因子,肝素和干细胞治疗急性心肌梗死
机译:干细胞联合经心肌可降解支架对猪急性心肌梗死模型的中期效果。
机译:衍生自MiR-146A改性的脂肪衍生的干细胞的外泌体衰减急性心肌梗死α诱导心肌损伤通过下调衍生自MiR-146A改性的脂肪衍生的干细胞的前期增长因子1 exosomes衰减急性心肌梗死?诱导心肌损伤 通过早期生长响应因子1的下调
机译:细胞外基质水凝胶作为生长因子递送系统,可在心肌梗塞的小动物模型中延长新型工程化HGF模拟物的释放并增强其作用
机译:骨髓源性干细胞治疗急性心肌梗死的评估
机译:原发性经皮冠状动脉介入治疗急性ST段抬高型心肌梗死患者外周血间充质干细胞干细胞归巢因子和血管生长因子的变化
机译:一种新的透射性神经性可降解支架与生长因子,肝素和干细胞联合在急性心肌梗死中